This is the limited version of the Santaris Pharma company profile: Join LinkedIn or Sign In to see more information.
Santaris Pharma A/S, a biopharmaceutical company, develops oncology drugs. It develops a class of RNAi drugs to switch off the expression of harmful genes. The company develops these drugs for the treatment of cancer and metabolic disorders. Santaris Pharma was founded as Pantheco A/S in 1998 and was renamed as Santaris Pharma A/S in 2003. Santaris Pharma is based in Horsholm, Denmark.
Your Connections to Santaris Pharma
Popular Profiles at Santaris Pharma
Last edited by Corporate Executive Assistant at Santaris Pharma
Boge Alle 3
Horsholm
2970
Denmark
Phone: 45 45 17 98 00
Fax: 45 45 17 98 98
| Top Schools |
| Københavns Universitet | 27% |
| Danmarks Tekniske Universitet | 8% |
| Syddansk Universitet | 8% |
| Handelshøjskolen i København | 6% |
| Danmarks Farmaceutiske Universitet | 5% |
|
Estimated based on LinkedIn Data
Career path for Santaris Pharma employees
Santaris Pharma employees are most connected to
News about Santaris Pharma
-
From: | December 03, 2009
-
From: | December 03, 2009
-
From: | December 03, 2009
In partnership with 
Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.
This LinkedIn Company Profile was created by LinkedIn and is about Santaris Pharma. This page is not endorsed by or affiliated with Santaris Pharma. For questions regarding LinkedIn Company Profiles, contact us.